Formulations and processing

WF Wanessa Costa Silva Faria
MG Morenna Alana Giordani
AA Ariadny da Silva Arcas
DC Daniela Fernanda Lima Carvalho Cavenaghi
AO Adriana Paiva de Oliveira
JS Jacqueline Fiuza dos Santos
WB Wander Miguel Barros
request Request a Protocol
ask Ask a question
Favorite

We developed three formulations (30-g each) substituting whey protein by isolated soy protein (ISP) at 25% (PB2), 50% (PB3), or 75% (PB1) weight/weight (Table 1), supplemented with soy isoflavones (44.48% w/w) as follow: different amounts of ISP and WPC were homogenised with others dry ingredients in a powder mixer, batter was made by adding dry ingredients to the wet ingredients (liquid and semi-solid), then the batter was shaped into a coated PVC container and placed overnight in freezer at −7 ± 1 °C, each PB was removed from PVC mould, wrapped and stored under refrigeration (10 ± 2 °C). 100 mg of isoflavones were homogeneously mixed in the batter, because concentration has been related with improvement in blood glucose levels between individual diabetics (Jayagopal et al. 2002; Curtis et al. 2012). To correct the isoflavones concentration to 100% we used 2.25 as correction factor.

Ingredients and proportions used in the formulation of 3 protein bars (PB1, PB2, and PB3)

Bold indicates proportion of substitution of whey protein by isolated soy protein in protein bar formulations at 25% (PB2), 50% (PB3), or 75% (PB1)

aDiluted in 1:50 parts of whey protein concentrate

b44.48% isoflavones containing 1.23% genistin, 0.14% genistein, 9.55% daidzein, 32.5% daidzein, 0.54% glycitein, and 0.52% glycitein, corrected by a factor of 2.24

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A